Erin E Foster
Overview
Explore the profile of Erin E Foster including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
49
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang J, Wallace A, Foster E, Kim S
Biochemistry
. 2018 Jan;
57(7):1274-1283.
PMID: 29368511
Peptidoglycan (PG) is a major component of the cell wall in Enterococcus faecalis. Accurate analysis of PG composition provides crucial insights into the bacterium's cellular functions and responses to external...
2.
Chang J, Foster E, Thadani A, Ramirez A, Kim S
J Bacteriol
. 2017 May;
199(15).
PMID: 28507244
Oritavancin is a lipoglycopeptide antibiotic that exhibits potent activities against vancomycin-resistant Gram-positive pathogens. Oritavancin differs from vancomycin by a hydrophobic side chain attached to the drug disaccharide, which forms a...
3.
Chang J, Foster E, Wallace A, Kim S
Sci Rep
. 2017 Apr;
7:46500.
PMID: 28406232
Vancomycin resistance is conferred upon vancomycin-resistant enterococci (VRE) through the replacement of peptidoglycan (PG) stem terminal d-Ala-d-Ala with d-Ala-d-Lac. The d-Ala-d-Lac incorporation can affect both the fitness and virulence of...
4.
Chang J, Foster E, Yang H, Kim S
Biochemistry
. 2017 Jan;
56(4):612-622.
PMID: 28040891
Induction of vancomycin resistance in vancomycin-resistant enterococci (VRE) involves replacement of the d-Ala-d-Ala terminus of peptidoglycan (PG) stems with d-Ala-d-Lac, dramatically reducing the binding affinity of vancomycin for lipid II....